Organon & Co.
OGN
$13.31
-$0.02-0.15%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.46B | 1.51B | 1.60B | 1.59B | 1.51B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.46B | 1.51B | 1.60B | 1.59B | 1.51B |
| Cost of Revenue | 670.00M | 741.00M | 733.00M | 701.00M | 663.00M |
| Gross Profit | 790.00M | 766.00M | 869.00M | 893.00M | 850.00M |
| SG&A Expenses | 424.00M | 431.00M | 415.00M | 453.00M | 420.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.19B | 1.26B | 1.23B | 1.25B | 1.18B |
| Operating Income | 273.00M | 244.00M | 370.00M | 345.00M | 334.00M |
| Income Before Tax | 213.00M | -148.00M | 243.00M | 229.00M | 101.00M |
| Income Tax Expenses | 67.00M | 57.00M | 83.00M | 84.00M | 14.00M |
| Earnings from Continuing Operations | 146.00M | -205.00M | 160.00M | 145.00M | 87.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 146.00M | -205.00M | 160.00M | 145.00M | 87.00M |
| EBIT | 273.00M | 244.00M | 370.00M | 345.00M | 334.00M |
| EBITDA | 359.00M | 340.00M | 462.00M | 434.00M | 418.00M |
| EPS Basic | 0.56 | -0.79 | 0.62 | 0.56 | 0.34 |
| Normalized Basic EPS | 0.41 | 0.25 | 0.61 | 0.49 | 0.49 |
| EPS Diluted | 0.55 | -0.79 | 0.61 | 0.56 | 0.33 |
| Normalized Diluted EPS | 0.40 | 0.25 | 0.61 | 0.49 | 0.48 |
| Average Basic Shares Outstanding | 260.37M | 260.17M | 259.98M | 259.94M | 257.86M |
| Average Diluted Shares Outstanding | 262.90M | 260.17M | 260.65M | 260.16M | 261.00M |
| Dividend Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.28 |
| Payout Ratio | 3.42% | -1.95% | 1.88% | 6.90% | 81.61% |